251. Lessons from Mirrors

Format:

Text

252. Lecture notes for a speech at the Pontifical Academy of Sciences

Format:

Text

253. Lecture notes for "Gene Structure and Function"

Format:

Text

254. Lab report on the study of the polynucleotide phosphorylase enzyme

Format:

Text

255. LINE-1: A Mammalian Transposable Element

Format:

Text

256. LINE-1: A Human Transposable Element

Format:

Text

257. Keynote address from "Symposium on Women in Biomedical Careers: Dynamics of Change"

Format:

Text

258. Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]

Format:

Text

259. How to Maintain U.S. Leadership in Biomedical Research

Format:

Text

260. Highly Repeated Sequences in Mammalian Genomes

Format:

Text

261. Group photograph of participants at the Gordon Research Conference on Nucleic Acids

Format:

Still Image

262. Genetics and Health

Format:

Text

263. Genetically Modified Organisms

Format:

Text

264. Gender Matters

Format:

Text

265. Excerpt from Volume 6 of Singer's lab notebooks

Format:

Text

266. Excerpt from Volume 25 of Singer's lab notebooks

Format:

Text

267. Excerpt from Volume 23 of Singer's lab notebooks

Format:

Text

268. Excerpt from Singer's unnumbered 1971-1972 lab notebook

Format:

Text

269. Draft of a speech at a birthday symposium for Leon Heppel

Format:

Text

270. Draft Statement on Creationism

Format:

Text

271. David Hogness speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA

Format:

Still Image

272. David Baltimore speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA

Format:

Still Image

273. Cover of Yale Alumni Magazine

Format:

Still Image

274. Cover memorandum about a Berkeley, California biohazards ordinance

Format:

Text

275. Committee on Risk and Decision Making

Format:

Text

276. Chart identifying group photograph participants at the Gordon Research Conference on Nucleic Acids

Format:

Text

277. Bill Moyers interview of Maxine Singer

Format:

Text

278. Behind the Endless Frontier

Format:

Text

279. Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines

Format:

Text

280. Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules

Format:

Text

281. Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules

Format:

Text

282. Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules

Format:

Text

283. Appendix H: Provisional Statement of the Conference Proceedings

Format:

Text

284. Appendix F: Cloned Eukaryotic DNA

Format:

Text

285. Appendix F: Cloned Eukaryotic DNA

Format:

Text

286. Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes

Format:

Text

287. Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes

Format:

Text

288. Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms

Format:

Text

289. Appendix C: Program of the International Conference on Recombinant DNA Molecules

Format:

Text

290. An Introduction to Genes and Patents

Format:

Text

291. A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research

Format:

Text

292. A Statement

Format:

Text

293. 1996 Annual Mendel Lecture, Villanova University

Format:

Text